2593:HK:HK-Herbs Generation Grp Hldg Ltd (HKD)

COMMON STOCK | Others |

Last Closing

USD 2.66

Change

-0.12 (-4.32)%

Market Cap

N/A

Volume

0.95M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-02 )

Largest Industry Peers for Others

ETFs Containing 2593:HK

UKDV:LSE SPDR S&P UK Dividend Aris.. 4.99 % 0.00 %

N/A

USD 0.09B
IUKD:LSE iShares UK Dividend UCITS 3.80 % 0.00 %

N/A

USD 0.83B
IPKW Invesco International Buy.. 2.90 % 0.55 %

N/A

USD 0.08B
FKUD:LSE First Trust United Kingdo.. 2.81 % 0.00 %

N/A

USD 2.75M
FKU First Trust United Kingdo.. 2.78 % 0.80 %

N/A

USD 0.06B
FEUI:LSE Fidelity Europe Quality I.. 2.56 % 0.00 %

N/A

USD 0.02B
FEP First Trust Europe AlphaD.. 0.98 % 0.80 %

N/A

USD 0.18B
FKU:LSE First Trust United Kingdo.. 0.00 % 0.00 %

N/A

USD 6.46M
FEQD:LSE Fidelity Europe Quality I.. 0.00 % 0.00 %

N/A

USD 0.01B
FEQP:LSE Fidelity Europe Quality I.. 0.00 % 0.00 %

N/A

USD 1.17M

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.32% 18% F 19% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.32% 18% F 19% F
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike